Evidence map›Paper›PMID 33114654›Full record

ReviewPharmacy (Basel, Switzerland)2020

Protecting the Herd: Why Pharmacists Matter in Mass Vaccination.

Lois Lee, Gregory M Peterson, Mark Naunton, Shane Jackson, Mary Bushell

Abstract readReview
In one paragraph

Review in Pharmacy (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Barriers and enablers to pharmacists' involvement in a novel immunisation programme.Exploratory research in clinical and social pharmacy · 2022
    Article
  7. Review
  8. Article
  9. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.International journal of environmental research and public health · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Expanded roles of community pharmacists in COVID-19: A scoping literature review.Journal of the American Pharmacists Association : JAPhA
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lois LeeDiscipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia.
Gregory M PetersonDiscipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia.ORCID 0000-0002-6764-3882
Mark NauntonDiscipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia.ORCID 0000-0002-6422-7170
Shane JacksonSchool of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7000, Australia.ORCID 0000-0001-8307-8257
Mary BushellDiscipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia.ORCID 0000-0002-9262-0113

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic is ongoing. The unprecedented challenges worldwide implore the urgent development of a safe and effective COVID-19 vaccine. Globally, pharmacists have been delivering important public health services as part of the COVID-19 response. It remains to be seen what role they will play once a vaccine is available. This review examines herd immunity and the potential role of the pharmacy profession in mass vaccination against COVID-19, particularly within the Australian context.

aimA literature review was conducted to review the global development of COVID-19 vaccines, and the Australian healthcare workforce capability and existing policy for mass vaccination and the potential role of the pharmacist.

methodScienceDirect, Scopus, The National Centre for Biotechnology Information (NCBI), Wiley Online Library, PubMed, and Google Scholar were used to search for relevant literature using keywords COVID-19, vaccines, immunisation, herd immunity, pandemic, pharmacist and Australian healthcare.

resultsA large portion of the literature was journal articles, and information from governmental and international bodies such as the World Health Organisation were often referenced. Over 20 million Australians need to be immunised through vaccination or acquire immunity through natural infection for the country to achieve herd immunity for COVID-19. When examining state and territory pandemic plans, pharmacists are underutilised. Modifying legislation to allow pharmacists to administer approved COVID-19 vaccines will enable a trained and skilled workforce to be deployed to increase the rate of mass vaccination.

conclusionIn preparation for a successful COVID-19 vaccine, the Australian Government must consider various elements in their vaccination policy. This includes the estimated herd immunity threshold, methods of vaccine delivery, vaccine clinic locations, staffing arrangements and training, and strategies for vaccine prioritisation. Pharmacists can and should play a key role in the roll out of mass COVID-19 vaccination.

Indexed as

Australian healthcareCOVID-19herd immunityimmunisationpandemicpharmacistpharmacyvaccine

Identifiers

PMID33114654
PMCPMC7712642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.